Vibrio cholerae Type VI Activity Alters Motility Behavior in Mucin.

Bacterial Proteins / genetics Cholera / metabolism Gene Expression Regulation, Bacterial Humans Intestine, Small / metabolism Mucins / metabolism Type VI Secretion Systems / genetics Vibrio cholerae / cytology
T6SS Vibrio motility mucin

Journal

Journal of bacteriology
ISSN: 1098-5530
Titre abrégé: J Bacteriol
Pays: United States
ID NLM: 2985120R

Informations de publication

Date de publication:
19 11 2020
Historique:
received: 30 04 2020
accepted: 11 08 2020
pubmed: 2 9 2020
medline: 22 4 2021
entrez: 2 9 2020
Statut: epublish

Résumé

Motility is required for many bacterial pathogens to reach and colonize target sites.

Identifiants

DOI: 10.1128/JB.00261-20 PMID: 32868403 PMC: PMC7685549
pubmed: 32868403
pii: JB.00261-20
doi: 10.1128/JB.00261-20
pmc: PMC7685549
pii:
doi:

Substances chimiques

Bacterial Proteins 0
Mucins 0
Type VI Secretion Systems 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

J Cell Sci. 2020 Mar 13;133(5):
pubmed: 32169835
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
EMBO J. 2015 Aug 13;34(16):2198-210
pubmed: 26194724
Nature. 1992 Jan 9;355(6356):182-4
pubmed: 1309599
Nat Commun. 2015 Nov 02;6:8776
pubmed: 26522289
Infect Immun. 2011 Jul;79(7):2941-9
pubmed: 21555399
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9769-74
pubmed: 18606988
Infect Immun. 2007 Dec;75(12):5550-8
pubmed: 17923517
Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8624-9
pubmed: 27439872
Curr Opin Cell Biol. 2012 Apr;24(2):262-8
pubmed: 22169400
Environ Microbiol. 2020 Oct;22(10):4167-4182
pubmed: 31355512
PLoS Pathog. 2014 Oct 02;10(10):e1004405
pubmed: 25275396
J Bacteriol. 2008 Oct;190(19):6439-47
pubmed: 18676667
Res Microbiol. 2008 Sep-Oct;159(7-8):545-9
pubmed: 18638548
FEMS Microbiol Lett. 2004 Oct 1;239(1):1-8
pubmed: 15451094
Mol Microbiol. 2007 Apr;64(1):57-67
pubmed: 17376072
PLoS One. 2012;7(10):e48320
pubmed: 23110230
Science. 2011 Oct 14;334(6053):255-8
pubmed: 21998396
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6889-94
pubmed: 11391007
J Bacteriol. 2011 Dec;193(23):6471-82
pubmed: 21949076
Toxins (Basel). 2015 Mar 18;7(3):919-35
pubmed: 25793724
Cell Microbiol. 2011 Oct;13(10):1542-57
pubmed: 21812888
J Bacteriol. 2009 Jun;191(11):3504-16
pubmed: 19329638
Int Microbiol. 2017 Sep;20(3):130-137
pubmed: 29446804
FEMS Microbiol Rev. 2018 Jan 1;42(1):
pubmed: 29069367
Anal Biochem. 2016 Jun 15;503:56-7
pubmed: 27036618
Infect Immun. 1994 Jul;62(7):2669-78
pubmed: 8005659
Appl Environ Microbiol. 2016 Sep 16;82(23):6881-6888
pubmed: 27637882
Trends Microbiol. 2017 Apr;25(4):267-279
pubmed: 28027803
Biophys J. 2015 Feb 3;108(3):766-74
pubmed: 25650943
Nat Commun. 2014 Sep 19;5:4913
pubmed: 25234699
mBio. 2019 Apr 23;10(2):
pubmed: 31015332
Methods Enzymol. 2012;504:183-200
pubmed: 22264535
Appl Environ Microbiol. 2016 Apr 18;82(9):2833-2842
pubmed: 26944842
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8937-42
pubmed: 24889608
Cell Host Microbe. 2013 Dec 11;14(6):652-63
pubmed: 24331463
Cell Signal. 2007 Jan;19(1):20-31
pubmed: 16870393
BMC Microbiol. 2014 Feb 04;14:22
pubmed: 24490592
Science. 2015 Jan 2;347(6217):63-7
pubmed: 25554784
J Bacteriol. 2018 Jul 25;200(16):
pubmed: 29760209
Infect Immun. 2012 Feb;80(2):575-84
pubmed: 22083711
Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):352-61
pubmed: 23478383
J Bacteriol. 2005 Dec;187(24):8403-10
pubmed: 16321945
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15508-13
pubmed: 17873062
Biophys J. 2010 Jan 6;98(1):12-7
pubmed: 20074512
Cell Rep. 2016 May 3;15(5):951-958
pubmed: 27117415
Infect Immun. 1999 Aug;67(8):3733-9
pubmed: 10417131
Cell. 2013 Feb 14;152(4):884-94
pubmed: 23415234
NPJ Biofilms Microbiomes. 2018 Apr 23;4:10
pubmed: 29707230
Mol Microbiol. 2001 Mar;39(6):1595-609
pubmed: 11260476
Pathog Dis. 2018 Feb 1;76(1):
pubmed: 29315383
Microbiol Mol Biol Rev. 2004 Jun;68(2):301-19
pubmed: 15187186
Nature. 2012 Feb 26;483(7388):182-6
pubmed: 22367545
J Bacteriol. 2018 Jul 10;200(15):
pubmed: 29555697
Nat Rev Microbiol. 2011 Apr;9(4):265-78
pubmed: 21407243
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4209-14
pubmed: 18337491
J Bacteriol. 2011 Oct;193(19):5260-70
pubmed: 21804008
Nat Rev Microbiol. 2011 Mar;9(3):153-65
pubmed: 21283116
Nature. 2000 Aug 3;406(6795):477-83
pubmed: 10952301
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5018-23
pubmed: 15037750
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2246-51
pubmed: 21205908
PLoS Negl Trop Dis. 2015 Aug 28;9(8):e0004031
pubmed: 26317760
Nat Commun. 2019 Aug 9;10(1):3595
pubmed: 31399579
mBio. 2012 May 01;3(3):
pubmed: 22550036
J Bacteriol. 2002 Mar;184(6):1767-71
pubmed: 11872729
Microbiol Mol Biol Rev. 2012 Dec;76(4):792-812
pubmed: 23204367
Cell Host Microbe. 2018 Feb 14;23(2):274-281.e2
pubmed: 29398650
PLoS Pathog. 2015 May 21;11(5):e1004787
pubmed: 25996593

Auteurs

Abby Frederick (A)

Department of Biology, Indiana University Bloomington, Bloomington, Indiana, USA.

Yuhsun Huang (Y)

Department of Biology, Indiana University Bloomington, Bloomington, Indiana, USA.

Meng Pu (M)

Department of Biology, Indiana University Bloomington, Bloomington, Indiana, USA.
Division of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Dean A Rowe-Magnus (DA)

Department of Biology, Indiana University Bloomington, Bloomington, Indiana, USA drowemag@indiana.edu.
Department of Molecular and Cellular Biochemistry, Indiana University Bloomington, Bloomington, Indiana, USA.
ORCID: 0000-0001-5133-4463

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › Vibrio cholerae Type VI Activity Alters...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Vibrio › Choléra › Vibrio cholerae Type VI Activity Alters...
questionsmedicales.fr › Phénomènes génétiques › Régulation de l'expression des gènes › Régulation de l'expression des gènes bactériens › Vibrio cholerae Type VI Activity Alters...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Vibrio cholerae Type VI Activity Alters...
questionsmedicales.fr › Système digestif › Tube digestif › Intestins › Intestin grêle › Vibrio cholerae Type VI Activity Alters...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Glycoprotéines › Mucoprotéines › Mucines › Vibrio cholerae Type VI Activity Alters...
questionsmedicales.fr › Structures macromoléculaires › Complexes multiprotéiques › Systèmes de translocation des protéines › Systèmes bactériens de sécrétion › Systèmes de sécrétion de type VI › Vibrio cholerae Type VI Activity Alters...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Vibrionaceae › Vibrio › Vibrio cholerae › Vibrio cholerae Type VI Activity Alters...